Page 1 of Clinical Trials for Peripheral T-cell Lymphoma, 449 Total Matches
- 1Active, not recruitingLast Updated: January 6, 2012Condition(s): Peripheral T-cell Lymphoma
- 2TerminatedLast Updated: September 16, 2011Condition(s): Peripheral T-Cell Lymphoma
- 3Active, not recruitingLast Updated: September 27, 2011Condition(s): Peripheral T-cell Lymphoma
- 4Active, not recruitingLast Updated: December 29, 2011Condition(s): Peripheral T-cell Lymphoma
- 5Active, not recruitingLast Updated: November 6, 2007Condition(s): Peripheral T-Cell Lymphoma
- 6RecruitingLast Updated: November 10, 2009Condition(s): Peripheral T-cell Lymphoma (Not Otherwise Specified); Angioimmunoblastic T-cell Lymphoma; Extranodal NK/T-cell Lymphoma Nasal Type; Enteropathy- Type T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative); Relapsed ALCL (ALK-1 Positive) Post Autologous Transplant
- 7RecruitingLast Updated: May 8, 2012Condition(s): Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma
- 8Active, not recruitingLast Updated: March 14, 2012Condition(s): Cutaneous T Cell Lymphoma; Peripheral T Cell Lymphoma
- 9TerminatedLast Updated: April 18, 2012Condition(s): Peripheral T-cell Lymphomas; Adult T-cell Leukemia; Adult T-cell Lymphoma; Peripheral T-cell Lymphoma Unspecified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma; T/Null Cell Systemic Type; Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease
- 10Active, not recruitingLast Updated: May 10, 2012Condition(s): Peripheral T-Cell Lymphoma
- 11RecruitingLast Updated: December 12, 2011Condition(s): Peripheral T-cell Lymphoma
- 12CompletedLast Updated: October 4, 2011Condition(s): Peripheral T-cell Lymphoma
- 13RecruitingLast Updated: March 27, 2012Condition(s): Peripheral T-cell Lymphoma
- 14Active, not recruitingLast Updated: April 11, 2012Condition(s): Peripheral T-Cell Lymphoma
- 15RecruitingLast Updated: May 22, 2012Condition(s): Peripheral T Cell Lymphoma Unspecified; Anaplastic Large Cell Lymphoma, ALK-negative; Angioimmunoblastic T Cell Lymphoma; Cutaneous T Cell Lymphoma
- 16RecruitingImmunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPLast Updated: May 4, 2012Condition(s): Peripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; Extranodal NK/T-cell Lymphoma
- 17Not yet recruitingLast Updated: May 2, 2012Condition(s): Lymphoma
- 18RecruitingLast Updated: April 9, 2012Condition(s): Leukemia; Lymphoma
- 19RecruitingLast Updated: July 21, 2011Condition(s): Enteropathy-Associated T-Cell Lymphoma; Anaplastic Large-Cell Lymphoma; Cutaneous T-Cell Lymphoma; Primary Cutaneous Anaplastic Large Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Peripheral T-Cell Lymphoma
- 20CompletedLast Updated: December 12, 2011Condition(s): Adult T-Cell Leukemia and Lymphoma (ATL); Adult Peripheral T-Cell Lymphoma (PTCL)
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Peripheral+T-cell+Lymphoma
